1. 70. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE pan-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION. (4th August 2020) Authors: Wheeler, Helen; Bacha, Jeffrey; Kanekal, Sarath; Pedersen, Harry; Sankar, Neil; Wang, Shen; Nesbit, Ian; Skoff, Kathy; Brown, Dennis Journal: Neuro-oncology advances Issue: Volume 2(2020)Supplement 2 Page Start: ii14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ACTR-06. CLINICAL TRIAL OF VAL-083 IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM: HALF-WAY REPORT. (11th November 2019) Authors: Chen, Zhong-ping; Guo, Chengcheng; Yang, Qun-ying; Li, Jia-wei; Wu, Shao-xiong; Bacha, Jeffrey; Johnson, Gregory; Langlands, John; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Lopez, Lorena; Brown, Dennis Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. (11th November 2019) Authors: O'Brien, Barbara; Penas-Prado, Marta; Kamiya, Carolos; Pei Weathers, Shiao-; Yung, Alfred; Loghin, Monica; Harrison, Rebecca; Bacha, Jeffrey; Brown, Dennis; Johnson, Gregory; Langlands, John; Schwartz, Richard; Kanekal, Sarath; Lopez, Lorena; deGroot, John Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ACTR-71. PHASE 1/2 STUDY OF DIANHYDROGALACTITOL (VAL-083) WITH RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED, MGMT-UNMETHYLATED GLIOBLASTOMA. (5th November 2018) Authors: Chen, Zhong-ping; Guo, Chengcheng; Bacha, Jeffrey; Steino, Anne; Langlands, John; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Lopez, Lorena; Brown, Dennis Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi27 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CSIG-02. VAL-083 INHIBITS PROLIFERATION OF A PANEL OF EIGHT GLIOBLASTOMA STEM CELL LINES: DOWNREGULATION OF BDR4 AS A NOVEL ANTI-NEOPLASTIC MECHANISM. (5th November 2018) Authors: Fernandez, Elise; Steino, Anne; Lesser, Glenn; Bacha, Jeffrey; Brown, Dennis; Kwatra, Madan Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTNI-01. A PHASE 1-2 CLINICAL TRIAL OF EO1001 (APL-122), A NOVEL IRREVERSIBLE PAN-ERBB INHIBITOR WITH PROMISING BRAIN PENETRATION. (12th November 2021) Authors: Frentzas, Sophia; Richardson, Gary; Bacha, Jeffrey; Kanekal, Sarath; Sankar, Neil; Shen, Wang; Redkar, Sanjeev; Lai, Chinglin; Yu, Peony; Nisbet, Ian; Skoff, Kathy; Wheeler, Helen; Pedersen, Harry; Zhong, Wang Zhen; Brown, Dennis Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CTNI-08. A PHASE 1–2 CLINICAL TRIAL OF EO1001, A NOVEL IRREVERSIBLE PAN-ErbB INHIBITOR WITH PROMISING BRAIN PENETRATION. (9th November 2020) Authors: Wheeler, Helen; Bacha, Jeffrey; Brown, Dennis; Kanekal, Sarath; Sankar, Neil; Nisbet, Ian; Skoff, Kathy; Shen, Wang; ZhenZhong, Wang; Pedersen, Harry Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CTNI-21. PHASE 2 STUDY OF VAL-083 AND RADIOTHERAPY IN NEWLY DIAGNOSED MGMT-UNMETHYLATED GBM. (12th November 2021) Authors: Chen, Zhong-ping; Guo, Cheng-Cheng; Qun-ying, Yang; Li, Jia-Wei; Wu, Shao-xiong; Bacha, Jeffrey; Johnson, Gregory; Langlands, John; Kwan, Claire; Kanekal, Sarath; Schwartz, Richard; Steino, Anne; Brown, Dennis Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CTNI-26. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. (12th November 2021) Authors: O'Brien, Barbara; Penas-Prado, Marta; Kamiya-Matsuoka, Carlos; Weathers, Shiao-Pei; Yung, W K Alfred; Loghin, Monica; Harrison, Rebecca; Majd, Nazanin; Knight, Stephanie; Bacha, Jeffrey; Brown, Dennis; Johnson, Gregory; Langlands, John; Schwartz, Richard; Kanekal, Sarath; Steino, Anne; Lopez, Lor... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. CTNI-72. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED, BEVACIZUMAB-NAÏVE GLIOBLASTOMA IN THE RECURRENT AND ADJUVANT SETTING. (9th November 2020) Authors: O'Brien, Barbara; Penas-Prado, Marta; Kamiya-Matsuoka, Carlos; Weathers, Shiao-Pei; Yung, W K Alfred; Loghin, Monica; Harrison, Rebecca; Majd, Nazanin; Bacha, Jeffrey; Brown, Dennis; Johnson, Greg; Langlands, John; Schwartz, Richard; Kanekal, Sarath; Steino, Anne; Lopez, Lorena; de Groot, John Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗